Mitratapide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMitratapide
Drug Alias NameYarvitanR-103757R 103757
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrosomal triglyceride transfer protein inhibitors
TargetsMicrosomal triglyceride transfer protein
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksKEGG